1,855
Views
4
CrossRef citations to date
0
Altmetric
Pulmonary Medicine

Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1659-1672 | Received 03 Jul 2021, Accepted 05 Sep 2021, Published online: 16 Sep 2021

References

  • Song WJ, Chang YS, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and Meta-analysis. Eur Respir J. 2015;45(5):1479–1481.
  • Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371(9621):1364–1374.
  • Song WJ, Chang YS, Faruqi S, et al. Defining chronic cough: a systematic review of the epidemiological literature. Allergy Asthma Immunol Res. 2016;8(2):146–155.
  • Morice AH, Fontana GA, Sovijarvi AR, et al.; ERS Task Force. The diagnosis and management of chronic cough. Eur Respir J. 2004;24(3):481–492.
  • Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):1S–23S.
  • Irwin RS, French CT, Lewis SZ, et al. Methodologies for the development of CHEST guidelines and expert panel reports. Chest. 2014;146(1):182– 889.
  • Song WJ, Won HK, Moon SD, et al. Could fractional exhaled nitric oxide test be useful in predicting inhaled corticosteroid responsiveness in chronic cough? A systematic review. J Allergy Clin Immunol Pract. 2017;5(1):135–143 e131.
  • Berry M, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007;62(12):1043–1049.
  • Gibson PG, Dolovich J, Denburg J, et al. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989;1(8651):1346–1348.
  • Ambrosino P, Parrella P, Formisano R, et al. Clinical application of nasal nitric oxide measurement in allergic rhinitis: a systematic review and Meta-analysis. Ann Allergy Asthma Immunol. 2020;125(4):447–459 e445.
  • Ambrosino P, Molino A, Spedicato GA, et al. Nasal nitric oxide in chronic rhinosinusitis with or without nasal polyps: a systematic review with Meta-Analysis. J Clin Med. 2020;9(1):200
  • Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The european respiratory society task force. Eur Respir J. 1997;10(7):1683–1693.
  • Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the american thoracic society was adopted by the ATS board of directors, july 1999. Am J Respir Crit Care Med. 1999;160(6):2104–2117.
  • American Thoracic S, European Respiratory S: ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930.
  • Dweik RA, Sorkness RL, Wenzel S, et al.; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010;181(10):1033–1041.
  • Maniscalco M, Bianco A, Mazzarella G, et al. Recent advances on nitric oxide in the upper airways. Curr Med Chem. 2016;23(24):2736–2745.
  • Hahn PY, Morgenthaler TY, Lim KG. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc. 2007;82(11):1350–1355.
  • Lamon T, Didier A, Brouquieres D, et al. Exhaled nitric oxide in chronic cough: a good tool in a multi-step approach. Respir Med Res. 2019;76:4–9.
  • Hsu JY, Wang CY, Cheng YW, Chou MC. Optimal value of fractional exhaled nitric oxide in inhaled corticosteroid treatment for patients with chronic cough of unknown cause. J Chin Med Assoc. 2013;76(1):15–19.
  • Prieto L, Ferrer A, Ponce S, et al. Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. Chest. 2009;136(3):816–822.
  • Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Whiting PF, Rutjes AW, Westwood ME, et al.; QUADAS-2 Group. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
  • Patel A, Cooper N, Freeman S, et al. Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of Meta-analysis of diagnostic test accuracy data. Res Synth Methods. 2021;12(1):34–44.
  • Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32(4):829–849.
  • Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–990.
  • Harbord RM, Deeks JJ, Egger M, et al. A unification of models for Meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8(2):239–251.
  • Caraguel CG, Vanderstichel R. The two-step fagan's nomogram: ad hoc interpretation of a diagnostic test result without calculation. Evid Based Med. 2013;18(4):125–128.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in Meta-analyses. BMJ. 2003;327(7414):557–560.
  • Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2:9.
  • Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
  • Burkner PC, Doebler P. Testing for publication bias in diagnostic Meta-analysis: a simulation study. Stat Med. 2014;33(18):3061–3077.
  • Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in Meta-analysis. Biometrics. 2000;56(2):455–463.
  • Sedgwick P, Marston L. How to read a funnel plot in a Meta-analysis. BMJ. 2015;351:h4718.
  • Malinovschi A, Janson C, Holmkvist T, et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J. 2006;28(2):339–345.
  • Dweik RA, Boggs PB, Erzurum SC, et al.; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. American thoracic society committee on interpretation of exhaled nitric oxide levels for clinical A: an official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615.
  • Koskela HO, Purokivi MK. Capability of hypertonic saline cough provocation test to predict the response to inhaled corticosteroids in chronic cough: a prospective, open-label study. Cough. 2013;9:15.
  • Watanabe K, Shinkai M, Shinoda M, et al. Measurement of eNO with portable analyser might improve the management of persistent cough at primary care practice in Japan. Clin Respir J. 2016;10(3):380–388.
  • Yi F, Chen R, Luo W, et al. Validity of fractional exhaled nitric oxide in diagnosis of Corticosteroid-Responsive cough. Chest. 2016;149(4):1042–1051.
  • Price DB, Buhl R, Chan A, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6(1):29–39.
  • Shebl E, Abdel-Moety H. Assessment of the role of fractional exhaled nitric oxide as a predictor of airway eosinophilia and corticosteroid responsiveness in patients with chronic cough. Egypt J Bronchol. 2020;14(1):15.
  • Li Y, Zhongmin Q, Hanjing L, et al. Clinical benefit of sequential three-step empirical therapy in the management of chronic cough. Respirology. 2008;13:353–358.
  • Lai K, Chen R, Lin J, et al. A prospective, multicenter survey on causes of chronic cough in China. Chest. 2013;143:613–620.
  • Molino A, Fuschillo S, Mosella M, et al. Comparison of three different exhaled nitric oxide analyzers in chronic respiratory disorders. J Breath Res. 2019;13(2):021002.
  • Heffler E, Carpagnano GE, Favero E, et al. Fractional exhaled nitric oxide (FENO) in the management of asthma: a position paper of the italian respiratory society (SIP/IRS) and italian society of allergy, asthma and clinical immunology (SIAAIC). Multidiscip Respir Med. 2020;15(1):36.
  • Wang K, Verbakel JY, Oke J, et al. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data Meta-analysis. Eur Respir J. 2020;55(5):1902150.
  • Wang X, Tan X, Li Q. Effectiveness of fractional exhaled nitric oxide for asthma management in children: a systematic review and Meta-analysis. Pediatr Pulmonol. 2020;55(8):1936–1945.
  • Wang Z, Pianosi PT, Keogh KA, et al. The diagnostic accuracy of fractional exhaled nitric oxide testing in asthma: a systematic review and Meta-analyses. Mayo Clin Proc. 2018;93(2):191–198.
  • Ponsioen BP, Hop WC, Vermue NA, et al. Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J. 2005;25(1):147–152.
  • Ye Q, He X-O, D’Urzo A. A review on the safety and efficacy of inhaled corticosteroids in the management of asthma. Pulm Ther. 2017;3(1):1–18.
  • Rytila P, Ghaly L, Varghese S, et al.; Airway Inflammation Study Group. Airway inflammation study G: Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J. 2008;32(4):989–996.
  • Lee SE, Lee JH, Kim HJ, et al. Inhaled corticosteroids and placebo treatment effects in adult patients with cough: a systematic review and Meta-analysis. Allergy Asthma Immunol Res. 2019;11(6):856–870.
  • Morice AH, McGarvey L, Pavord I.; British Thoracic Society Cough Guideline Group. British thoracic society cough guideline G: Recommendations for the management of cough in adults. Thorax. 2006;61(Suppl 1):i1–24.
  • Visca D, Beghe B, Fabbri LM, et al. Management of chronic refractory cough in adults. Eur J Intern Med. 2020;81:15–21.
  • Gao J, Wu F. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy Asthma Clin Immunol. 2018;14:21.
  • Sabatelli L, Seppala U, Sastre J, et al. Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89–97.
  • Buendia JA, Acuna-Cordero R, Rodriguez-Martinez CE. Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Eff Resour Alloc. 2021;19(1):33.
  • Leeflang MM, Deeks JJ, Gatsonis C, et al.; Cochrane Diagnostic Test Accuracy Working Group. Cochrane diagnostic test accuracy working G: Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149(12):889–897.
  • Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Statist Med. 1997;16(9):981–991.
  • Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation. 2013;36(5):1178–1185.
  • Rio Ramirez MT, Juretschke Moragues MA, Fernandez Gonzalez R, et al. Value of exhaled nitric oxide (FeNO) and eosinophilia during the exacerbations of chronic obstructive pulmonary disease requiring hospital admission. Copd. 2018;15(4):369–376.
  • Bersuch E, Graf F, Renner ED, et al. Lung function improvement and airways inflammation reduction in asthmatic children after a rehabilitation program at moderate altitude. Pediatr Allergy Immunol. 2017;28(8):768–775.
  • Clini E, Bianchi L, Foglio K, et al. Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease. Thorax. 2001;56(7):519–523.